Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2019-03-11 2019-03-11
Drug Identification Number 02371545 02371545
Brand name APO-VALSARTAN APO-VALSARTAN
Common or Proper name VALSARTAN VALSARTAN
Company Name APOTEX INC APOTEX INC
Ingredients VALSARTAN VALSARTAN
Strength(s) 320MG 320MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01 2014-10-01
Estimated end date
Actual end date 2018-12-27 2018-12-27
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Product discontinued Product discontinued
Health Canada comments